Home › Funds › Ball & Co Wealth Management Inc. › ONCY
Ball & Co Wealth Management Inc. position in ONCY
ONCOLYTICS BIOTECH INC · Health Care
Ball & Co Wealth Management Inc. reported holding 14,823 shares of ONCY (ONCOLYTICS BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$10K, representing 0.01% of its reported portfolio and ranking #28 among its reported holdings. Ball & Co Wealth Management Inc. has disclosed ONCY holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR
How Ball & Co Wealth Management Inc.'s ONCY position evolved
Ball & Co Wealth Management Inc. first disclosed a stake in ONCY in Q4 2024 at 4,393 shares (US$4K). The position peaked in Q3 2025 at 38,253 shares, worth US$53K. Across 7 filings, Ball & Co Wealth Management Inc. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 14,823 shares valued at US$10K. Notable position changes include a 726% increase in Q1 2025 (shares rose 40% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 4.39K | $4.00K | New |
| Q1 2025 | 36.29K | $19.00K | Add |
| Q2 2025 | 36.29K | $28.00K | Hold |
| Q3 2025 | 38.25K | $53.00K | Add |
| Q4 2025 | 38.25K | $33.00K | Hold |
| Q1 2026 | 38.25K | $32.00K | Hold |
| Q3 2026 | 14.82K | $9.90K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ONCY and 13F data
ONCY (ONCOLYTICS BIOTECH INC) is a Health Care company. 40 other funds we track also report a position in ONCY. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Ball & Co Wealth Management Inc.
FAQ
How long has Ball & Co Wealth Management Inc. held ONCY?
Ball & Co Wealth Management Inc. has disclosed ONCY holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
What is Ball & Co Wealth Management Inc.'s current position in ONCY?
As of Q3 2026, Ball & Co Wealth Management Inc. holds 14.82K shares of ONCY (ONCOLYTICS BIOTECH INC), valued at $9.90K, representing 0.01% of its reported portfolio and ranking #28.
Has Ball & Co Wealth Management Inc. been buying or selling ONCY?
In the latest 13F filing (Q3 2026), Ball & Co Wealth Management Inc. newly opened its position in ONCY. The position peaked in Q3 2025 at 38.25K shares.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.